RCS - MyCelx Tech. Corp. - PFAS System Validation

Mycelx TechnologiesAnnouncement

14/05/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210514:nRSN6053Ya&default-theme=true

RNS Number : 6053Y  MyCelx Technologies Corporation  14 May 2021

14 May 2021

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

PFAS System Validation

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water
and clean air technology experts, is pleased to announce validation and
capacity upgrade of its PFAS system at an Australian Department of Defence
location.

 

This follows a successful deployment of the PFAS system by our Australian
partner in 2018. The capacity upgrade contract was awarded as a consequence of
the robust operating performance demonstrated over a two-year period, within
budget, as well as allowing the customer to both support, improve and adhere
to, its environmental goals.

 

PFAS (Perfluoroalkyl substances) remediation has been a key area of organic
diversification for MYCELX and the Company is delighted with the progress
made. This re-deployment is a step forward for the Company and has the
potential to lead to further contract awards in due course. With the
increasing awareness and legislation worldwide, the benefits of MYCELX's
proprietary technology allows for efficient removal of toxic "forever"
chemicals associated with adhesives and Teflon related products and has the
potential to be a leading solution for PFAS remediation worldwide.

 

We look forward to updating shareholders further when the Company announces
its 2020 Full Year Results the week commencing 24 May 2021.

 

Connie Mixon, CEO, said:

 

"This is an important contract as it proves that our PFAS system is cost
effective, robust and reaffirms the rationale for our investment in this
market since 2018."

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                Tel: +1 888 306 6843

 Kim Slayton, CFO

 Celicourt

 Mark Antelme                     Tel: +44 20 8434 2754

 Jimmy Lea

 

About RNS Reach announcements

 

This is an RNS Reach announcement. RNS Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM quoted)
companies to distribute media only / non-regulatory news releases into the
public domain. Information required to be notified under the AIM Rules for
Companies, Market Abuse Regulation or other regulation would be disseminated
as an RNS regulatory announcement and not on RNS Reach.

 

Notes to Editors

 

Through its revolutionary oil-free water technology, MYCELX brings its
customers material benefits in terms of performance enhancement, cost savings
and significantly improved environmental footprints. Working beyond any
ordinary filtration methods, MYCELX's proprietary technology achieves oil
removal to less than one part per million.  MYCELX supports leading
international customers across the oil & gas value chain, as well as other
industrial users.   MYCELX also provides advanced air filtration technology
for manufacturing and industrial facilities, effectively removing oil
particles and biologicals to maintain continuous and safe air quality levels.

 

For more information, visit www.MYCELX.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAAJMPTMTJBBTB